Orosz Ferenc, Ovádi Judit
Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, POB 7, H-1518, Hungary.
J Immunol Methods. 2002 Dec 15;270(2):155-62. doi: 10.1016/s0022-1759(02)00295-8.
Previously, we have described a linearization procedure for the determination of dissociation constants of antigen-antibody interactions using data from enzyme-linked immunosorbent assays (ELISA) [J. Immunol. Methods 143 (1991) 119]. Here, we present a new linearization procedure-based partly on the former one-to evaluate quantitatively the data of displacement ELISAs. It renders possible the determination of dissociation constants of complexes formed between immobilised antigens and the displacing molecules without knowing the explicit concentration of the antigen and the dissociation constant and stoichiometry of the immunocomplex. In addition, determination of the concentration of specific antibody in the serum is not necessary since the equations use only the ratio of serum concentration and apparent dissociation constant of the immunocomplex (both of which can be expressed as serum dilutions). The method has been applied to determine the strength of immobilised hexokinase-tubulin interactions (K(d)=1.2 microM) from a displacement ELISA using antihexokinase serum. The applicability and limitations of the procedure are discussed on the basis of both the experimental and theoretical data.
此前,我们已经描述了一种线性化程序,用于利用酶联免疫吸附测定(ELISA)的数据来确定抗原-抗体相互作用的解离常数[《免疫学方法杂志》143(1991)119]。在此,我们提出一种新的线性化程序——部分基于前者——来定量评估竞争ELISA的数据。它使得在不知道固定抗原的明确浓度、免疫复合物的解离常数和化学计量比的情况下,能够确定固定抗原与竞争分子之间形成的复合物的解离常数。此外,由于这些方程仅使用血清浓度与免疫复合物表观解离常数的比值(两者都可以表示为血清稀释度),因此无需测定血清中特异性抗体的浓度。该方法已应用于通过使用抗己糖激酶血清的竞争ELISA来确定固定化己糖激酶-微管蛋白相互作用的强度(K(d)=1.2 microM)。基于实验和理论数据讨论了该程序的适用性和局限性。